Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.

Glaspy, John A; Wolf, Myles; Strauss, William E

Glaspy, John A; Wolf, Myles; Strauss, William E.

Glaspy JA; Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, Los Angeles, CA, 90095, USA. jglaspy@mednet.ucla.edu.
Wolf M; Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Strauss WE; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.

Adv Ther ; 38(7): 3531-3549, 2021 07.

Article en En | MEDLINE | ID: mdl-34053011

Asunto(s)

Anemia Ferropénica; Hipofosfatemia; Administración Intravenosa; Anemia Ferropénica/tratamiento farmacológico; Humanos; Hipofosfatemia/inducido químicamente; Infusiones Intravenosas; Hierro/uso terapéutico

Palabras clave

Ferric carboxymaltose; Ferric derisomaltose; Ferumoxytol; Iron deficiency anemia; Iron treatment; Iron-induced hypophosphatemia; Osteomalacia

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipofosfatemia / Anemia Ferropénica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google